This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sereno, D.
Right arrow Articles by Lemesre, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sereno, D.
Right arrow Articles by Lemesre, J. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 1998, p. 3097-3102, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Axenically Grown Amastigotes of Leishmania infantum Used as an In Vitro Model To Investigate the Pentavalent Antimony Mode of Action

D. Sereno,1 M. Cavaleyra,1 K. Zemzoumi,2 S. Maquaire,1 A. Ouaissi,2 and J. L. Lemesre1,*

Laboratoire de Biologie Parasitaire1 and CJF-INSERM No. 96/04,2 Centre ORSTOM, 34 032 Montpellier Cedex 1, France

Received 9 April 1998/Returned for modification 18 May 1998/Accepted 28 September 1998

The mechanism(s) of activity of pentavalent antimony [Sb(V)] is poorly understood. In a recent study, we have shown that potassium antimonyl tartrate, a trivalent antimonial [Sb(III)], was substantially more potent than Sb(V) against both promastigotes and axenically grown amastigotes of three Leishmania species, supporting the idea of an in vivo metabolic conversion of Sb(V) into Sb(III). We report that amastigotes of Leishmania infantum cultured under axenic conditions were poorly susceptible to meglumine [Glucantime; an Sb(V)], unlike those growing inside THP-1 cells (50% inhibitory concentrations [IC50s], about 1.8 mg/ml and 22 µg/ml, respectively). In order to define more precisely the mode of action of Sb(V) agents in vivo, we first induced in vitro Sb(III) resistance by direct drug pressure on axenically grown amastigotes of L. infantum. Then we determined the susceptibilities of both extracellular and intracellular chemoresistant amastigotes to the Sb(V)-containing drugs meglumine and sodium stibogluconate plus m-chlorocresol (Pentostam). The chemoresistant amastigotes LdiR2, LdiR10, and LdiR20 were 14, 26, and 32 times more resistant to Sb(III), respectively, than the wild-type one (LdiWT). In accordance with the hypothesis described above, we found that intracellular chemoresistant amastigotes were resistant to meglumine [Sb(V)] in proportion to the initial level of Sb(III)-induced resistance. By contrast, Sb(III)-resistant cells were very susceptible to sodium stibogluconate. This lack of cross-resistance is probably due to the presence in this reagent of m-chlorocresol, which we found to be more toxic than Sb(III) to L. infantum amastigotes (IC50s, of 0.54 and 1.32 µg/ml, respectively). Collectively, these results were consistent with the hypothesis of an intramacrophagic metabolic conversion of Sb(V) into trivalent compounds, which in turn became readily toxic to the Leishmania amastigote stage.

* Corresponding author. Mailing address: Laboratoire de Biologie Parasitaire, ORSTOM, 911 Av Agropolis, BP 5045, 34032 Montpellier Cedex 1, France. Phone: (33) 04 67 41 62 20. Fax: (33) 04 67 54 78 00. E-mail: lemesre{at}melusine.mpl.orstom.fr.

Antimicrobial Agents and Chemotherapy, December 1998, p. 3097-3102, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Vermeersch, M., da Luz, R. I., Tote, K., Timmermans, J.-P., Cos, P., Maes, L. (2009). In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences. Antimicrob. Agents Chemother. 53: 3855-3859 [Abstract] [Full Text]  
  • Singh, N., Gupta, R., Jaiswal, A. K., Sundar, S., Dube, A. (2009). Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. J Antimicrob Chemother 64: 370-374 [Abstract] [Full Text]  
  • Goyeneche-Patino, D. A., Valderrama, L., Walker, J., Saravia, N. G. (2008). Antimony Resistance and Trypanothione in Experimentally Selected and Clinical Strains of Leishmania panamensis. Antimicrob. Agents Chemother. 52: 4503-4506 [Abstract] [Full Text]  
  • Maharjan, M., Singh, S., Chatterjee, M., Madhubala, R. (2008). Role of Aquaglyceroporin (AQP1) Gene and Drug Uptake in Antimony-resistant Clinical Isolates of Leishmania donovani. Am J Trop Med Hyg 79: 69-75 [Abstract] [Full Text]  
  • MITTAL, M. K., RAI, S., ASHUTOSH, , RAVINDER, , GUPTA, S., SUNDAR, S., GOYAL, N. (2007). CHARACTERIZATION OF NATURAL ANTIMONY RESISTANCE IN LEISHMANIA DONOVANI ISOLATES. Am J Trop Med Hyg 76: 681-688 [Abstract] [Full Text]  
  • Mukherjee, A., Padmanabhan, P. K., Singh, S., Roy, G., Girard, I., Chatterjee, M., Ouellette, M., Madhubala, R. (2007). Role of ABC transporter MRPA, {gamma}-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59: 204-211 [Abstract] [Full Text]  
  • Ashutosh, , Sundar, S., Goyal, N. (2007). Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56: 143-153 [Abstract] [Full Text]  
  • Dumas, C., Chow, C., Muller, M., Papadopoulou, B. (2006). A Novel Class of Developmentally Regulated Noncoding RNAs in Leishmania. Eukaryot Cell 5: 2033-2046 [Abstract] [Full Text]  
  • Croft, S. L., Sundar, S., Fairlamb, A. H. (2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev. 19: 111-126 [Abstract] [Full Text]  
  • Decuypere, S., Rijal, S., Yardley, V., De Doncker, S., Laurent, T., Khanal, B., Chappuis, F., Dujardin, J.-C. (2005). Gene Expression Analysis of the Mechanism of Natural Sb(V) Resistance in Leishmania donovani Isolates from Nepal. Antimicrob. Agents Chemother. 49: 4616-4621 [Abstract] [Full Text]  
  • McNicoll, F., Muller, M., Cloutier, S., Boilard, N., Rochette, A., Dube, M., Papadopoulou, B. (2005). Distinct 3'-Untranslated Region Elements Regulate Stage-specific mRNA Accumulation and Translation in Leishmania. J. Biol. Chem. 280: 35238-35246 [Abstract] [Full Text]  
  • Breton, M., Tremblay, M. J, Ouellette, M., Papadopoulou, B. (2005). Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis. Infect. Immun. 73: 6372-6382 [Abstract] [Full Text]  
  • Zhou, Y., Messier, N., Ouellette, M., Rosen, B. P., Mukhopadhyay, R. (2004). Leishmania major LmACR2 Is a Pentavalent Antimony Reductase That Confers Sensitivity to the Drug Pentostam. J. Biol. Chem. 279: 37445-37451 [Abstract] [Full Text]  
  • Gourbal, B., Sonuc, N., Bhattacharjee, H., Legare, D., Sundar, S., Ouellette, M., Rosen, B. P., Mukhopadhyay, R. (2004). Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin. J. Biol. Chem. 279: 31010-31017 [Abstract] [Full Text]  
  • Brochu, C., Wang, J., Roy, G., Messier, N., Wang, X.-Y., Saravia, N. G., Ouellette, M. (2003). Antimony Uptake Systems in the Protozoan Parasite Leishmania and Accumulation Differences in Antimony-Resistant Parasites. Antimicrob. Agents Chemother. 47: 3073-3079 [Abstract] [Full Text]  
  • Sudhandiran, G., Shaha, C. (2003). Antimonial-induced Increase in Intracellular Ca2+ through Non-selective Cation Channels in the Host and the Parasite Is Responsible for Apoptosis of Intracellular Leishmania donovani Amastigotes. J. Biol. Chem. 278: 25120-25132 [Abstract] [Full Text]  
  • Murray, H. W. (2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother. 45: 2185-2197 [Full Text]  
  • Sereno, D., Holzmuller, P., Mangot, I., Cuny, G., Ouaissi, A., Lemesre, J.-L. (2001). Antimonial-Mediated DNA Fragmentation in Leishmania infantum Amastigotes. Antimicrob. Agents Chemother. 45: 2064-2069 [Abstract] [Full Text]  
  • Sereno, D., Roy, G., Lemesre, J. L., Papadopoulou, B., Ouellette, M. (2001). DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug Screening. Antimicrob. Agents Chemother. 45: 1168-1173 [Abstract] [Full Text]  
  • Frézard, F., Demicheli, C., Ferreira, C. S., Costa, M. A. P. (2001). Glutathione-Induced Conversion of Pentavalent Antimony to Trivalent Antimony in Meglumine Antimoniate. Antimicrob. Agents Chemother. 45: 913-916 [Abstract] [Full Text]  
  • Torres-Santos, E. C., Moreira, D. L., Kaplan, M. A. C., Meirelles, M. N., Rossi-Bergmann, B. (1999). Selective Effect of 2',6'-Dihydroxy-4'-Methoxychalcone Isolated from Piper aduncum on Leishmania amazonensis. Antimicrob. Agents Chemother. 43: 1234-1241 [Abstract] [Full Text]  
  • Shaked-Mishan, P., Ulrich, N., Ephros, M., Zilberstein, D. (2001). Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovani. J. Biol. Chem. 276: 3971-3976 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»